Skip to content
2000
Volume 7, Issue 2
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

The use and indications of anti-vascular endothelial growth factors (VEGF) are rapidly expanding, evolving and undergoing refinement in retinal diseases. This manuscript attempts to perform a critical appraisal of the diaspora of limited information available on the non- traditional applications (outside of AMD, DR and vascular occlusive diseases) and synthesize a review. As with any newer drug, only longitudinal studies will determine the true inherent value no matter how broad the current popular appeal appears to be due to very positive press. Although these drugs appear to be very effective in conventional applications, it is wise to deliberate prior to non-conventional use.

Loading

Article metrics loading...

/content/journals/cdth/10.2174/157488512800676057
2012-06-01
2025-10-05
Loading full text...

Full text loading...

/content/journals/cdth/10.2174/157488512800676057
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test